Spreadsheet: 74634ee1-cc72-460e-982d-5209122cd10d
Sheet: Sheet1

Test Referenced | Entry Type | Mayo ID | Description | Reporting Description | Method | Collection Container | Temperature | Stability | [NAME] | Unit of Measure | [NAME] | Minimum Volume | Reject Due To | Reference Values | Days/Times Performed | Analytic Time | Maximum Lab Time | CPT Units | CPT Code | LOINC® Code | LOINC® Attributes | Always Performed | Orderable Separately | Performing Location
HIQGP | Test | HIQGP | HIV-1 Quantification with Reflex to Genotypic Drug Resistance Analysis and Phenotypic Resistance Prediction, Plasma | HIV-1 Quant Reflex to Geno/Pheno, P | HIQGP/89402: Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) (PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.) GHIVR/88782: [NAME] Reaction (RT-PCR)/DNA Sequencing VPHIV/88781: Virtual Phenotype |  |  |  |  |  | Collection Container/Tube: Lavender top (EDTA) Submission Container/Tube: Plastic vial [NAME]: 3 mL Collection Instructions: 1. Spin down and remove plasma from cells within 6 hours of draw. 2. Freeze plasma specimen immediately, and ship specimen frozen on dry ice. 3. If shipment will be delayed for >24 hours, freeze plasma specimen at [NAME] (up to 35 days) until shipment on dry ice. Additional Information: This test can be used for detection and diagnosis of HIV-1 infections, including in children <18 months of age when serologic tests are not useful (due to presence of maternal HIV antibodies). | 2 mL | Hemolysis	Mild OK; Gross OK Thawing	Warm reject; Cold <24 hours OK, refreeze-note to laboratory Lipemia	Mild OK; [NAME] OK Icterus	NA Other	Green-top (heparin) tube | Undetected | HIV-1 quantification: Monday through Saturday; 7 a.m.-4 p.m. HIV-1 genotyping: varies; test will be performed in batches of 4. | 2 days | 10 days | 1 | 87536 |  |  |  |  | Rochester
HIQGP | [NAME] | PLEDTA | [NAME] |  |  |  | Frozen | 35 days
HIQGP | Result | 81958 | HIV-1 RNA Quantification, P | HIV-1 RNA Quantification, P | Numeric |  |  |  |  | copies/mL |  |  |  |  |  |  |  |  |  | 20447-9 | HIV 1 RNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar
HIQGP | [NAME] | VPHIV | HIV-1 Phenotypic Drug Resistance Prediction (Add-On) | HIV-1 Phenotypic Resist Prediction | Virtual Phenotype |  |  |  |  |  | No additional specimen is required. Laboratory will use DNA sequencing data from the HIV-1 genotyping test result (GHIV/82340 HIV-1 Genotypic Drug Resistance Mutation Analysis, [NAME]) obtained within the previous 3 months at MML. |  |  | An interpretive report will be provided.   Test performed by:  [NAME] BVBA Turnhoutseweg 30 2340 Beerse Belgium | Monday through Saturday; Varies | 24 hours | 7 days | 1 | 87900 |  |  | No | No
VPHIV | [NAME] | PLEDTA | [NAME] |  |  |  | Frozen | 35 days
VPHIV | Result | 88781 | HIV-1 Phenotypic Resist Prediction | HIV-1 Phenotypic Resist Prediction | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
HIQGP | [NAME] | [NAME] | HIV-1 Genotypic Drug Resistance Mutation Analysis, with Reflex to Phenotypic Drug Resistance Prediction, Plasma | HIV-1 Geno Reflex to Pheno Predict | GHIVR/88782: [NAME] Reaction (RT-PCR)/DNA Sequencing (PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.) VPHIV/88781: Virtual Phenotype |  |  |  |  |  | Collection Container/Tube: Lavender top (EDTA) Submission Container/Tube: Plastic vial [NAME]: 2 mL Collection Instructions: 1. Spin down and separate plasma from cells within 6 hours of collection. 2. Freeze plasma immediately and ship specimen frozen on dry ice. 3. If shipment will be delayed for >24 hours, freeze plasma at [NAME] (up to 35 days) until shipment on dry ice. Additional Information: 1. This test is intended to be used to monitor known HIV-positive infections. It is not intended for primary detection of HIV infections. 2. Specimens submitted for HIV-1 genotyping should contain > or =1,000 copies/mL of HIV-1 RNA. | 0.6 mL | Hemolysis	Mild OK; Gross OK Thawing	Warm reject; Cold <24 hours OK, refreeze-note to lab Lipemia	Mild OK; [NAME] OK Icterus	NA Other	Green-top (heparin) tube | Not applicable | Varies; test will be performed in batches of 4 | 2-3 days | 10 days | 1 | 87901 |  |  | No | Yes
[NAME] | [NAME] | PLEDTA | [NAME] |  |  |  | Frozen | 35 days
[NAME] | Result | 82340 | HIV-1 Genotypic Drug Resistance, P | HIV-1 Genotypic Drug Resistance, P | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 30554-0 | HIV reverse transcriptase gene mutations detected:Prid:Pt:Isolate:Nom:
[NAME] | Result | 21395 | Reverse Transcriptase Mutations | Reverse Transcriptase Mutations | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 30554-0 | HIV reverse transcriptase gene mutations detected:Prid:Pt:Isolate:Nom:
[NAME] | Result | 21411 | Abacavir | Abacavir | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 30287-7 | Abacavir:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 21406 | Didanosine | Didanosine | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 30284-4 | [NAME]:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 21412 | Lamivudine/Emtricitabine | Lamivudine/Emtricitabine | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 30283-6 | Lamivudine:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 21408 | Stavudine | Stavudine | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 30286-9 | Stavudine:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 21530 | Tenofovir | Tenofovir | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 41396-3 | Tenofovir:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 21405 | [NAME] | [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 30282-8 | Zidovudine:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 21414 | Efavirenz | Efavirenz | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 30291-9 | Efavirenz:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 31267 | Etravirine | Etravirine | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 52749-9 | Etravirine:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 21410 | Nevirapine | Nevirapine | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 30289-3 | Nevirapine:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 34917 | Rilpivirine | Rilpivirine | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 68463-9 | Rilpivirine:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 21400 | Protease Mutations | Protease Mutations | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 33630-5 | HIV protease gene mutations detected:Prid:Pt:Isolate:Nom:
[NAME] | Result | 23624 | Atazanavir | Atazanavir | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 41403-7 | Atazanavir:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 28076 | Atazanavir with [NAME] | Atazanavir with [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 49618-2 | Atazanavir+Ritonavir:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 26784 | Darunavir with [NAME] | Darunavir with [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 49630-7 | Darunavir+Ritonavir:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 26732 | Fosamprenavir | Fosamprenavir | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 43736-8 | Fosamprenavir:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 26733 | Fosamprenavir with [NAME] | Fosamprenavir with [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 51409-1 | Fosamprenavir+Ritonavir:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 21415 | Indinavir | Indinavir | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 30292-7 | Indinavir:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 26734 | Indinavir with [NAME] | Indinavir with [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 49619-0 | Indinavir+Ritonavir:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 21532 | Lopinavir with [NAME] | Lopinavir with [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 42000-0 | Lopinavir+Ritonavir:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 21416 | Nelfinavir | Nelfinavir | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 30294-3 | Nelfinavir:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 26735 | Saquinavir with [NAME] | Saquinavir with [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 49621-6 | Saquinavir+Ritonavir:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | Result | 28201 | [NAME] with [NAME] | [NAME] with [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 49622-4 | Tipranavir+Ritonavir:Susc:Pt:Isolate:OrdQn:Genotyping
[NAME] | [NAME] | VPHIV | HIV-1 Phenotypic Drug Resistance Prediction (Add-On) | HIV-1 Phenotypic Resist Prediction | Virtual Phenotype |  |  |  |  |  | No additional specimen is required. Laboratory will use DNA sequencing data from the HIV-1 genotyping test result (GHIV/82340 HIV-1 Genotypic Drug Resistance Mutation Analysis, [NAME]) obtained within the previous 3 months at MML. |  |  | An interpretive report will be provided.   Test performed by:  [NAME] BVBA Turnhoutseweg 30 2340 Beerse Belgium | Monday through Saturday; Varies | 24 hours | 7 days | 1 | 87900 |  |  | No | No
VPHIV | [NAME] | PLEDTA | [NAME] |  |  |  | Frozen | 35 days
VPHIV | Result | 88781 | HIV-1 Phenotypic Resist Prediction | HIV-1 Phenotypic Resist Prediction | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process